Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 827-833

  Remmers, Ann E ^a   Clark, Mary J ^a   Mansour, Alfred ^a,c   Akil, Huda ^c   Woods, James H ^b   Medzihradsky, Fedor ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLAZOCINE; ETHYLKETAZOCINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; LEVALLORPHAN; N ALLYLNORMETAZOCINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALORPHINE; NORBINALTORPHIMINE; OPIATE DERIVATIVE; PENTAZOCINE; TIFLUADOM;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHIRALITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; GLIOMA CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

ANALGESICS, OPIOID; ANIMALS; BENZENEACETAMIDES; GLIOMA; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PYRROLIDINES; RATS; RECEPTORS, OPIOID, KAPPA; STEREOISOMERISM; TRANSFECTION; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0033030242     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Blake AD, Bot G, Li S, Freeman JC and Reisine T (1997) Differential agonist regulation of the human kappa-opioid receptor. J Neurochem 68:1846-1852.
2. Chen C and Okayama H (1987) High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
3. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
4. Clark MJ, Emmerson PJ, Mansour AM, Akil H, Woods JH, Portoghese PS, Remmers AE and Medzihradsky F (1997) Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J Pharmacol Exp Ther 283:501-510.
5. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH and Medzihradsky F (1996) Characterization of opioid agonist efficacy in a C 6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther 278:1121-1127.
6. Emmerson PJ, Liu M, Woods JH and Medzihradsky F (1994) Binding affinity and selectivity of opioids at μ, δ and κ receptor in monkey brain membranes. J Pharmacol Exp Ther 271:1630-1637.
7. Fischel SV and Medzihradsky F (1981) Scatchard analysis of opiate receptor binding. Mol Pharmacol 20:269-279.
8. France CP, Medzihradsky F and Woods JH (1994) Comparison of kappa opioids in rhesus monkeys: Behavioral effects and receptor binding affinities. J Pharmacol Exp Ther 268:47-58.
9. Gairin JE, Botanch C, Cros J and Meunier J (1989) Binding of dynorphin A and related peptides to kappa-and μ-opioid receptors: Sensitivity to Na+ ions and Gpp(NH)P. Eur J Pharmacol 172:381-384.
10. Gutstein HB, Rubie EA, Mansour A, Akil H and Woodgett JR (1997) Opioid effects on mitogen-activated protein kinase signalling cascades. Anesthesiology 87:1118-1126.
11. Lawrence DMP and Bidlack JM (1992) Kappa opioid binding sites on the R1.1 murine lymphoma cell line: Sensitivity to cations and guanine nucleotides. J Neuroimmunol 41:223-230.
12. Lowry OH, Rosebrough NA, Farr AL and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
13. Mansson E, Bare L and Yang D (1994) Isolation of a human κ opioid receptor cdna from placenta. Biochem Biophys Res Commun 202:1431-1437.
14. Massotte D, Baroche L, Simonin F, Yu L, Kieffer B and Pattus F (1997) Characterization of delta, kappa and mu human opioid receptors overexpressed in baculovirus-infected insect cells. J Biol Chem 272:19987-19992.
15. McClane TK and Martin WR (1967) Effects of morphine, nalorphine, cyclazocine and naloxone on the flexor reflex. Int J Neuropharmacol 6:89-98.
16. Musacchio JM (1990) The psychotomimetic effects of opiates and the σ receptor. Neuropsychopharmacology 3:191-200.
17. 3 analgesic. J Pharmacol Exp Ther 257:1-7.
18. Portoghese PS, Lipkowski AW and Takemori AE (1987) Binaltorphimine and norbinaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 4:1287-1292.
19. α subunit and is similar to that of other opioid receptors. Mol Brain Res 25:336-346.
20. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI and Reisine T (1994) Pharmacological characterization of the cloned κ-, δ-, and μ opioid receptors. J Pharmacol Exp Ther 45:330-334.
21. Selley DE, Sim LJ, Xiao R, Liu Q and Childers SR (1997) μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 51:87-96.
22. Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattei M, Charron G, Bloch B and Kieffer B (1995) Kappa opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology and expression pattern in the central nervous system. Proc Natl Acad Sci USA 92:7006-7010.
23. Terasaki T, Deguchi Y, Sato H, Hirai K and Tsuji A (1991) In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood-brain barrier: An application of brain microdialysis. Pharm Res 8:815-820.
24. Terasaki T, Hirai K, Sato H, Kang YS and Tsuji A (1989) Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier. J Pharmacol Exp Ther 251:351-357.
25. 2-adrenergic receptor activation of G protein: Evidence for a precoupled receptor/G protein state. Mol Pharmacol 45:524-531.
26. 35S] thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
27. Walker EA, Butelman ER, Decosta BR and Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: Receptor mechanisms and temperature dependency. J Pharmacol Exp Ther 267:280-286.
28. Walker EA, Zernig G and Woods JH (1995) Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. J Pharmacol Exp Ther 273: 1345-1352.
29. Woods JH, Medzihradsky F, Smith CB, Winger GD and Gmerek D (1985) Evaluation of new compounds for opioid activity, in Problems of Drug Dependence (Harris LS ed) (Rockville, MD: NIDA Research Monograph 67, 1986) pp 453-489.
30. Yabaluri N and Medzihradsky F (1996) Down-regulation of μ opioid receptor by full, but not partial agonists is independent of G protein coupling. Mol Pharmacol 52:896-902.
31. 35S]GTPγS binding to membranes: Determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 282: 676-684.
32. 2 opioid receptors. Proc Natl Acad Sci USA 85:4061-4065.